Valiant Laboratories Limited has informed the Exchange regarding Outcome of Committee Meeting held on July 15, 2025.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Laboratories has approved the terms of its rights issue. The company will issue up to 1,08,62,500 fully paid-up equity shares of face value ₹10 each at an issue price of ₹75 per share (including a premium of ₹65). Total issue size is about ₹81.47 crores. Existing shareholders are entitled to 1 rights share for every 4 shares held on the record date of July 19, 2025. The rights issue opens on July 28, 2025 and closes on August 8, 2025, with full payment required on application. Post-issue, equity share count will rise from 4.34 crore to 5.43 crore shares assuming full subscription.
Eligible shareholders must decide whether to subscribe, renounce, or let the rights entitlement lapse by August 8, 2025. If fully subscribed, the share count expands by 25%, which will dilute existing shareholders' stake unless they fully exercise their entitlements.